Jessica Feehan, NP
Family · Canton, GANPI 1407290273
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (33.4%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 44 manufacturers reported payments, led by Axonics, Inc. at 56.4% of the total. 2025 is the largest year on record at $14,104, 3.4 times the $4,170 reported in 2021. Among family clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 528 payments — averaging $96.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Axonics, Inc.$29K
- Bayer$7K
- Boston Scientific$5K
- Telix Pharmaceuticals$2K
- Sumitomo Pharma America, Inc.$881
- Teleflex LLC$876
- plus $7K from 38 others
What the payments were for
- Consulting fees$10,36520%
- Speaking & faculty fees$8,38017%
- Travel & lodging$14,78029%
- Food & beverage$16,92333%
- Education$2551%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Axonics$25,344
- Nubeqa$5,862
- Bulkamid$2,355
- ILLUCCIX$1,879
- Axonics r-SNM System$1,698
- UroLift System$385
- LYNPARZA$250
- Erleada$201
- GENERAL - THERAPIES$175
- AquaBeam Robotic System$161
- GENTLECATH$147
- UroLift$146
- myRisk$145
- CVAC Aspiration System$138
- iTIND System$129
- Nanoknife$126
- ORGOVYX$115
- Optilume BPH Drug Coated Balloon Catheter$112
- GEMTESA$112
- PYLARIFY$111
How this compares
$50,702 in reported general payments places this provider in the 95th percentile of 6,258 family providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ErleadaApalutamide | 31 | $454,738 |
| NubeqaDarolutamide | 12 | $160,275 |
| OrgovyxRelugolix | 59 | $151,293 |
| GemtesaVibegron | 181 | $138,556 |
| MyrbetriqMirabegron | 99 | $81,386 |
| Methenamine Hippurate | 242 | $18,403 |
| ElmironPentosan Polysulfate Sodium | 12 | $12,013 |
| Estradiol | 121 | $7,727 |
| Tamsulosin Hcl | 345 | $4,833 |
| Testosterone | 13 | $2,930 |
| Testosterone Cypionate | 31 | $1,935 |
| Finasteride | 72 | $1,112 |
| NitrofurantoinNitrofurantoin Macrocrystal | 40 | $1,092 |
| Silodosin | 15 | $483 |
| Dutasteride | 11 | $334 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonErleada | $675 | $454,73831 claims |
| Sumitomo Pharma America, Inc.Orgovyx, Gemtesa | $881 | $289,849240 claims |
| BayerNubeqa | $6,607 | $160,27512 claims |
| Astellas Pharma US IncMyrbetriq | $663 | $81,38699 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 6,258 family providers in Georgia.
Other family in Canton
- Julia ThorneCanton$39K
- Allie McAllisterMarietta$299K
- Erin HenryLawrenceville$135K
- Trisha RomanPeachtree City$134K
- Lori ReedMarietta$106K
- Julia BranchCumming$102K
- Hannah BanachWaycross$85K
- Morgan GroothandEvans$81K
- Anna Carolina WrightLilburn$69K
- Stacey TatroeAtlanta$38K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.